insights_auto
Why is TMCI up 2,05%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
4,48 $
arrow_upward
+2,05%(+0,090) 1D
5 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,40 $
High
4,54 $
Low
4,24 $
Mkt. cap
291,35 մլն
Avg. vol.
238,13 հզր
Volume
210,72 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
Open
4,40 $
High
4,54 $
Low
4,24 $
Mkt. cap
291,35 մլն
Avg. vol.
238,13 հզր
Volume
210,72 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
News stories
From web sources and news partners
Simply Wall Street
·
25 րոպե առաջ
Did New Science Board Just Shift BioCryst's (BCRX) Investment Narrative?
Stock Titan
·
44 րոպե առաջ
Five new hires’ options vest over four years, if they stay
Investor's Business Daily
·
6 րոպե առաջ
Nasdaq Breaks Out To New Highs; Shopify, Taiwan Semiconductor, Guardant Health In Focus
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc